Page last updated: 2024-10-29

ifosfamide and Hematologic Malignancies

ifosfamide has been researched along with Hematologic Malignancies in 4 studies

Research Excerpts

ExcerptRelevanceReference
" Major treatment-related adverse events were grade 3 or more hematologic toxicities, which included lymphopenia corresponding to dose-limiting toxicity."2.75Activity and safety of combination chemotherapy with methotrexate, ifosfamide, l-asparaginase and dexamethasone (MILD) for refractory lymphoid malignancies: a pilot study. ( Hosone, M; Isobe, Y; Katsuoka, Y; Komatsu, N; Oshimi, K; Shimizu, S; Sugimoto, K; Tsukune, Y; Yasuda, H, 2010)
"Ifosfamide is an alkylating agent with a broad spectrum of activity in solid tumors and hematological malignancies."2.42Ifosfamide in hematological malignancies of adults. ( Elice, F; Rodeghiero, F, 2003)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sato, S1
Tanaka, E1
Tamai, Y1
Tsukune, Y1
Isobe, Y1
Yasuda, H1
Shimizu, S1
Katsuoka, Y1
Hosone, M1
Oshimi, K1
Komatsu, N1
Sugimoto, K1
Rodeghiero, F1
Elice, F1
Dazzi, C1
Cariello, A1
Rosti, G1
Monti, G1
Sebastiani, L1
Argnani, M1
Nicoletti, P1
Tienghi, A1
Leoni, M1
Fiorentini, G1
Turci, D1
Giovanis, P1
De Giorgi, U1
Marangolo, M1

Reviews

1 review available for ifosfamide and Hematologic Malignancies

ArticleYear
Ifosfamide in hematological malignancies of adults.
    Oncology, 2003, Volume: 65 Suppl 2

    Topics: Adult; Antineoplastic Agents, Alkylating; Burkitt Lymphoma; Hematologic Neoplasms; Hodgkin Disease;

2003

Trials

1 trial available for ifosfamide and Hematologic Malignancies

ArticleYear
Activity and safety of combination chemotherapy with methotrexate, ifosfamide, l-asparaginase and dexamethasone (MILD) for refractory lymphoid malignancies: a pilot study.
    European journal of haematology, 2010, Volume: 84, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Female; Hematologic Neopl

2010

Other Studies

2 other studies available for ifosfamide and Hematologic Malignancies

ArticleYear
Blastic plasmacytoid dendritic cell neoplasm with response to pralatrexate.
    Annals of hematology, 2019, Volume: 98, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Dendritic Cells

2019
Peripheral blood progenitor cell (PBPC) mobilization in heavily pretreated patients with germ cell tumors: a report of 34 cases.
    Bone marrow transplantation, 1999, Volume: 23, Issue:6

    Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combin

1999